J Cusato, A Manca, A Palermiti, J Mula, M Antonucci, F Chiara, A De Nicolò, Tommaso Lupia, Giacomo Stroffolini, L Boglione, A D'Avolio
Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact?
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
following 200 increase central lineassociated bloodstream infection clabsi standardized infection ratio private teaching hospital 2019 2020 program utilization clabsi prevention registered nurse implemented reduce clabsis variety focused prevention efforts education clabsi prn project consisted dedicated team rns performed interventions included audit central lines daily realtime education remediation biweekly educational handouts assistance 2person dressing changes audit data utilized identify trends gaps compliance clabsi bundle ie daily bathing dressing integrity clabsi rate1000 central line days tracked preintervention intervention postintervention time periods intervention clabsi rate decreased 14 preintervention time period 04 intervention time period pvalue 04 additionally daily bathing compliance improved 843 preintervention time period 908 intervention time period pvalue 004 implementation clabsi prn beneficial reducing clabsis experttrained role dedicated central line management reduces clabsi occurrences reduces health care costs improves patient outcomes